An introduction to mitochondria in lung biology and disease

S. Meiners (München, Germany)

Source: International Congress 2018 – Mitochondrial dysfunction as a driver of lung disease
Session: Mitochondrial dysfunction as a driver of lung disease
Session type: Symposium
Number: 1629

Slide presentationWebcast

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Meiners (München, Germany). An introduction to mitochondria in lung biology and disease. International Congress 2018 – Mitochondrial dysfunction as a driver of lung disease

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The environment, epigenetics and lung disease
Source: Annual Congress 2013 –PG6 Epigenetics of asthma and COPD
Year: 2013

Pathology and molecular biology of lung cancer
Source: Annual Congress 2006 - PG19 - Thoracic oncology: diagnostic assessment of lung cancer
Year: 2006



Stem cells, lung pathogenesis and therapeutic potential
Source: Annual Congress 2005 - Scientific year in review
Year: 2005

Role of biomarkers for early detection of lung cancer and chemoprevention
Source: Eur Respir J 2002; 19: 1151-1158
Year: 2002



Host–microbe cross-talk in the lung microenvironment: implications for understanding and treating chronic lung disease
Source: Eur Respir J, 56 (2) 1902320; 10.1183/13993003.02320-2019
Year: 2020



Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology
Source: Eur Respir J 2010; 35: 496-504
Year: 2010



Introduction “Current perspectives of molecular pathology and functional genomics in neoplastic lung disease”
Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer
Year: 2009

The genetics of interstitial lung diseases
Source: Eur Respir Rev, 28 (153) 190053; 10.1183/16000617.0053-2019
Year: 2019



Pathogenesis of lung cancer signalling pathways: roadmap for therapies
Source: Eur Respir J 2009; 33: 1485-1497
Year: 2009



What shall we do with the damaged proteins in lung disease? Ask the proteasome!
Source: Eur Respir J 2012; 40: 1260-1268
Year: 2012



The role of molecular pathology in diagnosis and treatment of lung cancer
Source: Annual Congress 2007 - PG9 - Molecular pathology and genetics in lung diseases
Year: 2007



Impact of interstitial lung disease and simultaneous lung cancer on therapeutic possibilities and survival
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019

The biology of lung cancer
Source: Eur Respir Mon; 2009: 44: 88–105
Year: 2009

The mitochondrion revisited: an overview of its role in lung inflammation and lung ageing
Source: ERS Lung Science Conference 2020
Year: 2020

Cellular mechanisms of paediatric lung disease
Source: Virtual Congress 2020 – Paediatric year in review
Year: 2020

Biomarker discovery, development, and implementation in interstitial lung diseases
Source: Virtual Congress 2021 – Interstitial lung diseases: from disease mechanisms to novel treatment options
Year: 2021


Prevalence and characterization of interstitial lung disease in a lung cancer screening program
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Year: 2019